Safety of Imatinib Mesylate in a Multicenter Expanded Access Program in Adult Patients with Gastrointestinal Stromal Tumors in the Adjuvant Setting
FI: 1,483
Tipo: Article
Colaboración
Año: 2019
Autores
Reichardt, P; Schlemmer, M; Perez, JRD; Papai, Z; Prausova, J; Melichar, B; Fumagalli, E; Barone, C; Bauer, S; Pustowka, A; Crippa, S; Castellana, R; Quiering, C; Le Cesne, A
Revista
Título: ONCOLOGY RESEARCH AND TREATMENT
Cuartil
- Q4